Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000586376 | SCV000695288 | likely pathogenic | X-linked agammaglobulinemia | 2017-01-24 | criteria provided, single submitter | clinical testing | Variant summary: The BTK c.371G>A (p.Trp124X) variant results in a premature termination codon, predicted to cause a truncated or absent BTK protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.982C>T, p.Gln328X; c.1455C>A, p.Tyr485X; c.1558C>T, p.Arg520X). One in silico tool predicts a damaging outcome for this variant. This variant is absent in 86517 control chromosomes but has been reported in at least 2 affected individuals in the literature (Wang_2009, Hashimoto_1996). Taken together, this variant is classified as likely pathogenic. |
Labcorp Genetics |
RCV003512058 | SCV004300178 | pathogenic | X-linked agammaglobulinemia with growth hormone deficiency | 2022-11-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 492811). This variant is also known as 503G>A. This premature translational stop signal has been observed in individual(s) with X-linked agammaglobulinemia (PMID: 8695804). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Trp124*) in the BTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BTK are known to be pathogenic (PMID: 15661032, 16862044, 19419768). |
Clinical Molecular Genetics Laboratory, |
RCV000584393 | SCV000692186 | pathogenic | Autosomal recessive agammaglobulinemia 1 | 2009-07-21 | no assertion criteria provided | clinical testing |